Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.5498
+0.0878 (19.00%)
At close: Apr 25, 2025, 4:00 PM
0.5533
+0.0035 (0.64%)
Pre-market: Apr 28, 2025, 5:24 AM EDT

Psyence Biomedical Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22
Cash & Equivalents
1.930.731.331.76
Cash & Short-Term Investments
1.930.731.331.76
Cash Growth
219.35%-45.05%-23.97%-
Other Receivables
0.130.040.150.04
Receivables
0.130.040.150.04
Prepaid Expenses
0.160.320.080.01
Restricted Cash
0.030.030.030.03
Total Current Assets
2.241.131.591.83
Property, Plant & Equipment
0.010.01--
Total Assets
2.251.131.591.83
Accounts Payable
0.810.561.630.04
Accrued Expenses
0.010.130.160.09
Short-Term Debt
1.310.45--
Other Current Liabilities
1.390.97--
Total Current Liabilities
3.5112.11.790.13
Total Liabilities
3.5112.11.790.13
Common Stock
52.9446.135.931.7
Retained Earnings
-54.5-57.46-6.3-
Comprehensive Income & Other
0.30.360.17-
Shareholders' Equity
-1.26-10.97-0.21.7
Total Liabilities & Equity
2.251.131.591.83
Total Debt
1.310.45--
Net Cash (Debt)
0.63-9.711.331.76
Net Cash Growth
---23.97%-
Net Cash Per Share
1.04-111.8020.01-
Filing Date Shares Outstanding
0.610.180.07-
Total Common Shares Outstanding
0.610.180.07-
Working Capital
-1.27-10.98-0.21.7
Book Value Per Share
-2.07-61.46-3.01-
Tangible Book Value
-1.26-10.97-0.21.7
Tangible Book Value Per Share
-2.07-61.46-3.01-
Machinery
0.010.01--
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q